Parasites trigger epithelial cell crosstalk to drive gut–brain signalling
Article Title: Parasites trigger epithelial cell crosstalk to drive gut–brain signalling
Article Date: 25 March 2026
Article URL: https://www.nature.com/articles/s41586-026-10281-5
Article Image: (none provided)
Summary
This study reveals a two-step epithelial signalling cascade in the small intestine that links parasite detection to brain circuits controlling feeding. Tuft cells — specialised chemosensory epithelial cells — release acetylcholine (ACh) in two modes: an acute TRPM5-dependent burst when stimulated (for example by succinate) and a prolonged, constitutive “leak-like” release during type 2 inflammation (tuft cell hyperplasia). ACh acts on muscarinic receptors (notably Chrm3) on crypt-resident enterochromaffin (EC) cells, driving substantial serotonin release. Serotonin then activates 5-HT3 receptors on mucosal vagal afferents that project to the nucleus of the solitary tract (nTS), producing reduced food intake during established parasitic infection or IL-25/IL-4-induced type 2 responses.
The authors used organoids, genetically encoded biosensors, isolated-cell assays, pharmacology and multiple mouse models (tuft-cell-deficient Pou2f3−/−, epithelial Chat conditional knockouts, tetanus-toxin-blocked EC cells and Nippostrongylus brasiliensis infection) to map this epithelial-to-neural pathway and show behavioural consequences (feeding suppression) that depend on tuft-cell-derived ACh and EC-cell serotonin release.
Key Points
- Tuft cells release ACh acutely (TRPM5-dependent) and constitutively during type 2 inflammation (IL-4/IL-25-driven tuft-cell hyperplasia).
- ACh selectively activates crypt-resident EC cells via muscarinic ACh receptors (Chrm3), triggering large serotonin release.
- Serotonin from EC cells engages mucosal vagal afferents through 5-HT3 receptors and activates a distinct nTS neuronal population.
- The epithelial tuft→EC→vagal axis is most strongly engaged during established type 2 immune responses or helminth infection, not by brief acute tuft-cell stimulation alone.
- Genetic loss of tuft cells (Pou2f3−/−) or loss of ChAT in epithelial cells prevents ACh-driven EC activation, vagal signalling and the feeding suppression seen in infection or IL-25/IL-4 models.
- Blocking EC-cell transmitter release (tetanus toxin) or 5-HT3 signalling (alosetron) reduces vagal activation and attenuates feeding suppression, showing EC cells are a critical relay.
- Findings explain how parasite progression (sparse early colonisation → tuft-cell hyperplasia) can move hosts from asymptomatic detection to aversive gut–brain responses such as appetite suppression.
Why should I read this?
Quick heads-up — this paper actually ties together immune sensing, epithelial chemistry and brain signalling in a neat, experimentally solid chain. If you care about how the gut talks to the brain (appetite, nausea, visceral symptoms) or about mechanisms of parasite pathology, this saves you the slog of reading a dozen separate papers: tuft cells → ACh → EC cells → serotonin → vagus → nTS → less eating. It also flags new molecular nodes worth targeting if you want to tweak symptoms or diagnostics for parasitic and type 2 inflammatory states.
Context and relevance
Previous work established tuft cells as initiators of type 2 immunity and EC cells as gut chemosensors that drive nociceptive neural pathways. This study bridges those streams by showing direct paracrine epithelial crosstalk that recruits the vagal gut–brain axis. The result is mechanistic insight into why gastrointestinal symptoms (reduced appetite, discomfort, nausea-like behaviour) intensify as parasitic infections progress and tuft-cell numbers rise. The findings are relevant to researchers in mucosal immunology, neurogastroenterology and translational groups exploring symptom management in helminth or protist infections, and may inform biomarker or therapeutic strategies that target epithelial signalling rather than systemic immunosuppression.
Author style
Punchy: This is a tight, methodologically diverse study that convincingly maps an epithelial two-step messenger cascade to a defined vagal–brain outcome. The genetic and functional dissection (organoids, biosensors, pharmacology, infection models) makes the claims robust and the pathway actionable — worth attention for anyone studying gut sensory biology or trying to alleviate parasite-driven symptoms.
